Opioid Overdose-Related Emergency Department Visits Pre- and Post-COVID-19
Western Journal of Emergency Medicine · 10.06.2026 · 27 (4)
DOI: 10.5811/westjem.53227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Western Journal of Emergency Medicine, online erschienen am 10.06.2026. Verfasst von Melanie F Molina und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, Department of Emergency Medicine, San Francisco, California. Hauptthemen laut MEDLINE: Emergency Room Visits, Emergency Service, Hospital, COVID-19, Opiate Overdose. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Introduction
Understanding changes in opioid overdose-related emergency department (ED) visits and ED-based opioid use disorder (OUD) treatment post-coronavirus disease 2019 (COVID-19) pandemic can inform ongoing efforts to address the opioid crisis. We aimed to examine trends in opioid overdose-related ED visits, ED-based medication for OUD (MOUD) treatment, and appendicitis-related ED visits (as a control) before and after the initial COVID-19 peak in April 2020.
Methods
We conducted an interrupted time series analysis of monthly ED visits from January 2017–December 2022 at three hospitals in California. We modeled pre- and post-COVID-19 visit trends and the change in trend from pre- to post-COVID-19 peak using linear regression controlling for study site. Our primary outcome included monthly rates of opioid overdose-related ED visits, with monthly rates of ED visits with MOUD treatment as a secondary outcome. Appendicitis-related visits served as a control for temporal trends.
Results
Of the 781,488 ED visits across the entire study period, there were 2,536 (0.32%) opioid overdose-related visits, 9,755 (1.25%) MOUD treatment visits, and 1,123 (0.14%) appendicitis-related visits. Pre-pandemic, monthly increases were observed in opioid overdose-related visits (6.7 visits/10,000 per month, 95% confidence interval [CI] 2.6-10.8, P = .001), MOUD-positive visits (34.9 visits/10,000 per month, 95% CI, 26.0-43.7, P < .001), and appendicitis visits (2.5 visits/10,000 per month, 95% CI, 1.2-3.9, P < .001). After April 2020, only MOUD-positive visits showed an immediate (level change) increase (49 visits/10,000 or 34% of April 2020 projected pre-COVID-19 visit rates, 95% CI, 26.1-71.9, P < .001), with opioid overdose-related visits subsequently declining (-4.6 visits/10,000 per month or -11% of April 2020 projected pre-COVID-19 visit rates, 95% CI, -7.2 to -2.0, P = .001). Across the entire pre- to post-COVID-19 period, significant decreases in overall visit trends were observed across all visit types, greatest for MOUD-positive visits (-39.2 visits/10,000 per month, or -27% of April 2020 projected pre-COVID-19 visit rates, 95% CI, -51.5 to -26.8, P < .001), followed by opioid overdose visits (-11.3 visits/10,000 per month, or -27% of April 2020 projected pre-COVID-19 visit rates, 95% CI, -16.1 to -6.5, P < .001) and appendicitis visits (-4.2 visits/10,000 per month, or -23% of April 2020 projected pre-COVID-19 visit rates, 95% CI, -7.2 to -1.2, P = .01).
Conclusion
From pre- to post-initial COVID-19 peak, absolute ED-based MOUD treatment trends declined over three times faster than those of opioid overdose-related ED visits (although percentage changes relative to expected April 2020 rates were both -27%). These findings may reflect reduced perceived urgency as overdose presentations decreased and a shift away from crisis-driven implementation, underscoring the need for intentional integration of MOUD into routine ED practice to sustain treatment capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California, San Francisco, Department of Emergency Medicine, San Francisco, California.
- University of California, San Francisco, Philip R. Lee Institute for Health Policy Studies, San Francisco, California.
- University of California, Berkeley, Department of Statistics, Berkeley, California.
- University of California, Davis, Department of Emergency Medicine, Sacramento, California.
Förderung
- NIDA NIH HHS
Zitieren
APA
Molina, M. F., Pimentel, S. D., Raven, M. C., LeSaint, K. T., & Dillon, D. G. (2026). Opioid Overdose-Related Emergency Department Visits Pre- and Post-COVID-19. Western Journal of Emergency Medicine, 27(4). https://doi.org/10.5811/westjem.53227
Vancouver
Molina MF, Pimentel SD, Raven MC, LeSaint KT, Dillon DG. Opioid Overdose-Related Emergency Department Visits Pre- and Post-COVID-19. Western Journal of Emergency Medicine. 2026;27(4). doi:10.5811/westjem.53227
BibTeX
@article{Molina2026,
author = {Molina, Melanie F and Pimentel, Samuel D and Raven, Maria C and LeSaint, Kathy T and Dillon, David G},
title = {Opioid Overdose-Related Emergency Department Visits Pre- and Post-COVID-19},
journal = {Western Journal of Emergency Medicine},
year = {2026},
volume = {27},
number = {4},
doi = {10.5811/westjem.53227}
}
EUVIMED